- Global Pharma News & Resources

Press Releases - 2019-02-11

Date Title Company
11-Feb-2019 FDA Accepts sBLA and Grants Priority Review for BAVENCIO® (avelumab) Plus INLYTA® (axitinib) for the Treatment of Advanced Renal Cell Carcinoma EMD Serono
11-Feb-2019 IntraBio Investigational New Drug Application Approved by the FDA for the Treatment of Tay-Sachs and Sandhoff Disease IntraBio
11-Feb-2019 Nektar Therapeutics to Webcast Conference Call with Urothelial Cancer Specialist for Analysts & Investors at the 2019 ASCO Genitourinary Cancers Symposium Nektar Therapeutics
11-Feb-2019 Aurora Cannabis Announces Financial Results for the Second Quarter of Fiscal 2019 Aurora Cannabis Inc.
11-Feb-2019 Phase 3 ARCHES Trial Shows XTANDI® (enzalutamide) Significantly Improved Radiographic Progression-Free Survival in Men with Metastatic Hormone-Sensitive Prostate Cancer Astellas Pharma Inc.
11-Feb-2019 Opioid Perspectives for Government Payers Reveals a Road Map for Addressing National Crisis Telligen
11-Feb-2019 Applied BioMath, LLC Announces Marjoleen Nijsen, PhD as Speaker at February Quantitative Systems Pharmacology (QSP) Industry & Academia Symposium Applied BioMath, LLC
11-Feb-2019 Statement from FDA Commissioner Scott Gottlieb, M.D., on new data demonstrating rising youth use of tobacco products and the agency's ongoing actions to confront the epidemic of youth e-cigarette use U.S. Food and Drug Administration
11-Feb-2019 FDA takes action against 17 companies for illegally selling products claiming to treat Alzheimer's disease U.S. Food and Drug Administration
11-Feb-2019 Statement from FDA Commissioner Scott Gottlieb, M.D., on the agency's new efforts to strengthen regulation of dietary supplements by modernizing and reforming FDA's oversight U.S. Food and Drug Administration
11-Feb-2019 Mylan to Release 2018 Fourth Quarter and Full Year Results and 2019 Guidance on Feb. 26, 2019 Mylan N.V.
11-Feb-2019 OWC Pharmaceutical Research Corp, Letter to Shareholders OWC Pharmaceutical Research Corp.
11-Feb-2019 Geyser Brands Inc. Announces Signing of Letter of Intent to Acquire Brands Geyser Brands Inc.
11-Feb-2019 Precision BioLogic Launches Product to Improve Inhibitor Testing for People With Hemophilia A Precision BioLogic
11-Feb-2019 Prescription Opioid Use and Challenging Choices KJT Group, Inc.
11-Feb-2019 METAvivor and Presenting Sponsor Eisai Inc. Join Forces with AnaOno Intimates to Bring to Life the #ThisIsMBC Elements Campaign through Fashion Eisai Inc.
11-Feb-2019 Biofrontera AG: Biofrontera implements new Falsified Medicines Directive Biofrontera AG
11-Feb-2019 Liht Cannabis Corp.  Earns EnvirOganic Certification In Las Vegas, Nevada Liht Cannabis Corporation
11-Feb-2019 AbbVie and Teneobio Announce a Strategic Transaction to Develop a New Treatment for Multiple Myeloma AbbVie
11-Feb-2019 Genome Medical Expands Clinical Team to Meet Growing Demand for Genetic Expertise Genome Medical